McKerracher, Lisa
Shenkar, Robert http://orcid.org/0000-0002-1300-6845
Abbinanti, Matthew
Cao, Ying
Peiper, Amy
Liao, James K.
Lightle, Rhonda
Moore, Thomas
Hobson, Nicholas
Gallione, Carol
Ruschel, Joerg
Koskimäki, Janne
Girard, Romuald
Rosen, Kenneth
Marchuk, Douglas A.
Awad, Issam A.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (1R44NS095420-01)
Article History
Received: 24 June 2019
Revised: 1 August 2019
Accepted: 13 August 2019
First Online: 24 August 2019
Compliance with Ethical Standards
:
: Dr. McKerracher, CEO of BioAxone, holds an ownership interest in the company and has a significant competing interest. Drs. Matthew Abbinanti, Ken Rosen, and Joerg Ruschel were employees of BioAxone and have a modest conflict of interest. Drs. Doug Marchuk and Issam Awad were recipients of sponsored research through the SBIR grant to BioAxone. The other authors declare no conflict of interest.
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. All animal protocols were approved by the Tufts University Institutional Animal Care and Use Committee (IACUC) or the Duke University IACUC, and mice were bred at Duke University in compliance with the NIH Guide for the Care and Use of Laboratory Animals.